SciELO - Scientific Electronic Library Online

 
vol.26 número3Diagnóstico y tratamiento de aldosteronismo primarioPrevalencia de factores de riesgo cardiovascular en América Latina: una revisión de la evidencia publicada de 2010 a 2015 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista mexicana de cardiología

versión impresa ISSN 0188-2198

Resumen

SANCHEZ-TURCIOS, Reinaldo Alberto. Pheochromocytomas: diagnosis and treatment. Rev. Mex. Cardiol [online]. 2015, vol.26, n.3, pp.118-124. ISSN 0188-2198.

Pheochromocytomas are neoplasms that have their origin in chromaffin cells of the adrenal medulla. 80 to 90% of these are located in one of the adrenal glandules. This pathology is characterized by multiple symptoms that constitute a complex, heterogeneous clinical frame with a high rate of cardiovascular morbidity and mortality. The main secretion is catecholamine metabolites: metanephrine and normetanephrine. Diagnosis is carried out by determining free metanephrines in plasma (not conjugated) and fractioned metanephrines in 24-hour urine collection. Its location through different image procedures is fundamental. Preoperative treatment is initiated with a adrenergic antagonist and by adding, after a week, b adrenergic antagonists. Trans-operative treatment requires a multidisciplinary team of medical experts. This treatment is of vital importance and depends on the size and existence of metastasis. In some cases, adrenal retroperitoneal laparoscopy is preferred. However, an anterior approach is used when the tumor is > 6 cm, but other physicians have considered a 6 cm to 15 cm size. Transoperative follow up is a vital procedure for the patient. Paragangliomas are extra-adrenal ganglia pheochromocytomas.

Palabras llave : Pheochromocytoma; catecholamine metabolites; surgical treatment.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons